Dermatology Update 2018 FALL

SESSIONS & ABSTRACTS

MONTREAL, FAIRMONT THE QUEEN ELIZABETH - NOVEMBER 15-18, 2018

Blocking IL-17 Receptor A: What could this mean for your patient?

LEARNING OBJECTIVES

  • Overview of the SILIQ mode of action and the relevancy to clinical practice
  • Review of SILIQ safety data; It’s not the drug, it’s the disease
  • Recently published SILIQ efficacy data and early clinical experience with SILIQ

PART OF THE EVENT

Missing Event Data
Dr. David Adam

Dr. David Adam

Dermatologist, Toronto, ON

Dr. Leon Kircik

Dr. Leon Kircik

Dermatologist, Louisville, Kentucky

Bausch Health Companies Inc.